Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
44,736,322
-
Share change
-
+147,850
-
Total reported value
-
$1,254,917,338
-
Put/Call ratio
-
392%
-
Price per share
-
$28.08
-
Number of holders
-
143
-
Value change
-
+$7,899,154
-
Number of buys
-
71
-
Number of sells
-
74
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q1 2021
As of 31 Mar 2021,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,736,322 shares.
The largest 10 holders included
Alphabet Inc., PFM Health Sciences, LP, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, EcoR1 Capital, LLC, STATE STREET CORP, BOXER CAPITAL, LLC, BVF INC/IL, and Invus Financial Advisors, LLC.
This page lists
143
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.